Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evelyne Schvoerer

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Virologie (Montrouge, France)|August 2, 2021
[How genetic variability of hepatitis E virus (VHE) may impact its clinical relevance and transmission]Cédric Hartard, Hélène Jeulin, Evelyne Schvoerer
Viruses|July 2, 2021
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral VariantsAhlam Chaqroun, Cédric Hartard, Evelyne Schvoerer
World Journal of Gastroenterology|February 23, 2013
Clinical impact of hepatitis B and C virus envelope glycoproteinsHélène Jeulin, Aurélie Velay, John Murray, et al.
Virology|June 21, 2023
The presence of RNA cargo is suspected to modify the surface hydrophobicity of the MS2 phageGuillaume Bastin, Christophe Gantzer, Evelyne Schvoerer, et al.
Reviews in Medical Virology|August 29, 2019
Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challengeCédric Hartard, Christophe Gantzer, Jean-Pierre Bronowicki, et al.
Clinical Chemistry and Laboratory Medicine|July 31, 2021
Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabsCédric Hartard, Sibel Berger, Thomas Josse, et al.
The Journal of Infection|January 19, 2024
SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracingJohn M Murray, Daniel D Murray, Evelyne Schvoerer, et al.
Bulletin De L'Academie Nationale De Medecine|February 26, 2004
[Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches]Françoise Stoll-Keller, Evelyne Schvoerer, Christine Thumann, et al.
Clinical Laboratory|May 10, 2016
Evaluation of Virological Microparticle Enzyme Immunoassay According to the ISO 15189: Real-Life Experience in a University HospitalSophie Lafontaine, Christine Prin-Mathieu, Aurélie Velay, et al.
Infection, Disease & Health|June 1, 2022
SARS-CoV-2 seroprevalence in healthcare workers and risk factorsStéphanie Weber, Alice Didelot, Nelly Agrinier, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Virologie (Montrouge, France)|August 2, 2021
[How genetic variability of hepatitis E virus (VHE) may impact its clinical relevance and transmission]Cédric Hartard, Hélène Jeulin, Evelyne Schvoerer
Viruses|July 2, 2021
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral VariantsAhlam Chaqroun, Cédric Hartard, Evelyne Schvoerer
World Journal of Gastroenterology|February 23, 2013
Clinical impact of hepatitis B and C virus envelope glycoproteinsHélène Jeulin, Aurélie Velay, John Murray, et al.
Virology|June 21, 2023
The presence of RNA cargo is suspected to modify the surface hydrophobicity of the MS2 phageGuillaume Bastin, Christophe Gantzer, Evelyne Schvoerer, et al.
Reviews in Medical Virology|August 29, 2019
Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challengeCédric Hartard, Christophe Gantzer, Jean-Pierre Bronowicki, et al.
Clinical Chemistry and Laboratory Medicine|July 31, 2021
Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabsCédric Hartard, Sibel Berger, Thomas Josse, et al.
The Journal of Infection|January 19, 2024
SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracingJohn M Murray, Daniel D Murray, Evelyne Schvoerer, et al.
Bulletin De L'Academie Nationale De Medecine|February 26, 2004
[Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches]Françoise Stoll-Keller, Evelyne Schvoerer, Christine Thumann, et al.
Clinical Laboratory|May 10, 2016
Evaluation of Virological Microparticle Enzyme Immunoassay According to the ISO 15189: Real-Life Experience in a University HospitalSophie Lafontaine, Christine Prin-Mathieu, Aurélie Velay, et al.
Infection, Disease & Health|June 1, 2022
SARS-CoV-2 seroprevalence in healthcare workers and risk factorsStéphanie Weber, Alice Didelot, Nelly Agrinier, et al.
Pageof 6